» Authors » Matthew C Wolfgang

Matthew C Wolfgang

Explore the profile of Matthew C Wolfgang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 4235
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lukasiewicz A, Leistra A, Hoefner L, Monzon E, Gode C, Zorn B, et al.
Front Mol Biosci . 2025 Mar; 12:1493891. PMID: 40051501
(PA) is a ubiquitous, Gram-negative, bacteria that can attribute its survivability to numerous sensing and signaling pathways; conferring fitness due to speed of response. Post-transcriptional regulation is an energy efficient...
2.
Higgs M, Greenwald M, Roca C, Macdonald J, Sidders A, Conlon B, et al.
bioRxiv . 2024 Nov; PMID: 39484600
frequently causes chronic lung infection in individuals with muco-obstructive airway diseases (MADs). Chronic infections are difficult to treat, primarily owing to antibiotic treatment failure, which is often observed in the...
3.
Hickman E, Roca C, Zorn B, Rebuli M, Robinette C, Wolfgang M, et al.
Nicotine Tob Res . 2024 Jul; 27(1):114-124. PMID: 39018186
Introduction: Previous research suggests that e-cigarettes can alter immune function, including in the nasal mucosa, in unique ways. The respiratory microbiome plays a key role in respiratory host defense, but...
4.
Greenwald M, Meinig S, Plott L, Roca C, Higgs M, Vitko N, et al.
mBio . 2024 Apr; 15(6):e0345123. PMID: 38651896
Importance: Antibiotic treatment failure in chronic lung infections is associated with increased morbidity and mortality, illustrating the clinical challenge of bacterial infection control. Understanding the underlying infection environment, as well...
5.
Roca C, Alkhateeb A, Deanhardt B, Macdonald J, Chi D, Wang J, et al.
PLoS One . 2024 Mar; 19(3):e0301016. PMID: 38547181
Saliva is a readily accessible and inexpensive biological specimen that enables investigation of the oral microbiome, which can serve as a biomarker of oral and systemic health. There are two...
6.
Zhang Y, Bharathi V, Dokoshi T, de Anda J, Ursery L, Kulkarni N, et al.
Proc Natl Acad Sci U S A . 2024 Feb; 121(6):e2300644120. PMID: 38306481
It is unclear how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads to the strong but ineffective inflammatory response that characterizes severe Coronavirus disease 2019 (COVID-19), with amplified immune...
7.
Greenwald M, Meinig S, Plott L, Roca C, Higgs M, Vitko N, et al.
bioRxiv . 2024 Jan; PMID: 38187602
Importance: Antibiotic treatment failure in chronic lung infections is associated with increased morbidity and mortality, illustrating the clinical challenge of bacterial infection control. Understanding the underlying infection environment, as well...
8.
Einarsson G, Sherrard L, Hatch J, Zorn B, Johnston E, McGettigan C, et al.
J Cyst Fibros . 2023 Dec; 23(2):252-261. PMID: 38158284
Background: Whether there is any benefit in integrating culture-independent molecular analysis of the lower airway microbiota of people with cystic fibrosis into clinical care is unclear. This study determined the...
9.
Cholon D, Greenwald M, Higgs M, Quinney N, Boyles S, Meinig S, et al.
Cells . 2023 Nov; 12(22). PMID: 37998353
People with cystic fibrosis (pwCF) suffer from chronic and recurring bacterial lung infections that begin very early in life and contribute to progressive lung failure. CF is caused by mutations...
10.
Genito C, Darwitz B, Greenwald M, Wolfgang M, Thurlow L
Microbiol Spectr . 2023 Nov; 11(6):e0229923. PMID: 37933971
Individuals with diabetes are prone to more frequent and severe infections, with many of these infections being polymicrobial. Polymicrobial infections are frequently observed in skin infections and in individuals with...